Top 6 digital health megadeals of ’23

In the first quarter, digital health funding exceeded the final two quarters of 2022, but 2023 is still on pace for its slowest year since 2019, according to Rock Health.

Advertisement

The quarter also experienced a return of the “megadeal,” with six funding rounds in the nine figures, matching the total for the last two quarters of 2022 combined, the April 3 report found. The $203 million landed by clinical trials platform Paradigm in January marked the biggest series A digital health funding round ever.

Here are those huge deals ranked, according to the study:

1. Monogram Health: $375 million

2. ShiftKey: $300 million

3. Paradigm: $203 million

4. ShiftMed: $200 million

5. Gravie: $179 million

6. Vytalize Health: $100 million

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.